Renaissance Technologies (RenTech)'s ASTH Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 104,546 shares of Astrana Health, Inc. (ASTH) worth $2.56 M, representing 0.00% of the portfolio. First purchased in 2020-Q4, this medium-term investment has been held for 19 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in ASTH, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 149,300 shares. Largest reduction occurred in Q2 2025, reducing 93,100 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Astrana Health (ASTH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Astrana Health (ASTH) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +11,400 | Add 12.24% | 104,546 | $24.52 |
| Q4 2025 | +10,346 | Add 12.50% | 93,146 | $24.81 |
| Q3 2025 | -12,800 | Reduce 13.39% | 82,800 | $28.35 |
| Q2 2025 | -93,100 | Reduce 49.34% | 95,600 | $24.88 |
| Q1 2025 | -29,200 | Reduce 13.40% | 188,700 | $31.01 |
| Q4 2024 | +149,300 | Add 217.64% | 217,900 | $31.53 |
| Q3 2024 | +19,400 | Add 39.43% | 68,600 | $57.94 |
| Q2 2024 | +16,700 | Add 51.38% | 49,200 | $40.56 |
| Q1 2024 | +8,700 | Add 36.55% | 32,500 | $42.00 |
| Q4 2023 | +16,100 | Add 209.09% | 23,800 | $38.32 |
| Q3 2023 | +7,700 | New Buy | 7,700 | $30.91 |
| Q2 2023 | -40,475 | Sold Out | 0 | $0.00 |
| Q1 2023 | -25,225 | Reduce 38.39% | 40,475 | $0.04 |
| Q4 2022 | +65,700 | New Buy | 65,700 | $0.03 |
| Q4 2021 | -4,300 | Sold Out | 0 | $0.00 |
| Q3 2021 | -54,400 | Reduce 92.67% | 4,300 | $91.16 |
| Q2 2021 | +10,800 | Add 22.55% | 58,700 | $62.81 |
| Q1 2021 | -8,500 | Reduce 15.07% | 47,900 | $27.10 |
| Q4 2020 | +56,400 | New Buy | 56,400 | $18.26 |
Renaissance Technologies (RenTech)'s Astrana Health Investment FAQs
Renaissance Technologies (RenTech) first purchased Astrana Health, Inc. (ASTH) in Q4 2020, acquiring 56,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Astrana Health, Inc. (ASTH) for 19 quarters since Q4 2020.
Renaissance Technologies (RenTech)'s largest addition to Astrana Health, Inc. (ASTH) was in Q4 2024, adding 217,900 shares worth $6.87 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 104,546 shares of Astrana Health, Inc. (ASTH), valued at approximately $2.56 M.
As of the Q1 2026 filing, Astrana Health, Inc. (ASTH) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Astrana Health, Inc. (ASTH) was 217,900 shares, as reported at the end of Q4 2024.